Blog

The Best Hepatitis C Treatment

What is the best Hepatitis C Treatment?

Every day I get emails from people around the world asking for advice about Hepatitis C treatment. They are asking about which medicine they should get and what price they should pay and how long they should do the Hepatitis C treatment for.

Now I am not a doctor and have no formal medical training but I have lived and breathed Hepatitis C seven days a week 365 days a year since 2014 when I first learned that I was infected with Hepatitis C.

Whilst I am not a medical man I do, however, have a Bachelor of Arts degree, a Diploma in Education and a Masters Degree in History and I was 6 months into my PhD when I learned I had Hep C. So I am no dummy and I am quite capable of doing serious formal research.

So in this post I am going to show you which is the best, and most affordable, Hepatitis C treatment based on the results of solid scientific research done by many different internationally recognised research groups.

And I am going to say now that the best value all round Hep C treatment is Sofosbuvir 400 mg + Daclatasvir 60. In almost every situation, for every genotype Sofosbuvir + Daclatasvir is equal to, or better than, Epclusa, Maviret or Harvoni and it is also the least expensive at US$550 for a 12 weeks treatment.

Background

In 2014 I was six months into my PhD at the University of Tasmania when I suddenly became very, very sick. To cut a long story short I discovered that I had Hepatitis C.

Back in 2014 the only treatment option I could access was Sovaldi, but it was more than $100,000 for a treatment, which I did not have. So in May 2015 I went to India and purchased generic Sovaldi and I treated myself with a combination of Sovaldi (Sofosbuvir 400 mg) + Ribavirin. Three months later I was cured.

Later that year generic Harvoni became available and then generic Daclatasvir and then generic Epclusa. Then Mavyret arrived on the scene.

With the availability of so many new treatments, and with the drug companies spending vast fortunes on advertising it became hard to decide which Hepatitis C treatment was actually the best.

Below are graphs from various studies that show how the different drug combinations perform against the different Hepatitis C genotypes. Look through them yourself and make up your own mind. I have made a little comment at the bottom of each graph.

 

 

Mavyret Vs Sofosbuvir + Daclatasvir for Hep C Genotype 3

Maviret vs Sofosbuvir + Daclatasvir

This graph compares Mavyret (G/P) with Sofosbuvir + Daclatasvir for treating Hep C genotype 3. As you see Sof + Dac is superior to Mavyret

Harvoni for Hep C Genotype 1. 12 weeks vs 24 weeks

harvoni

This Graph shows that 12 weeks treatment with Harvoni gives a 95% cure rate for people without cirrhosis. It also demonstrates the fact that “The Longer the Treatment the Higher the Cure Rate”

 

Epclusa for all genotypes of Hep C. 12 weeks vs 24 weeks. Treatment with and without Ribavirin

Epclusa

This graph shows that 12 weeks treatment with Epclusa (Sof+ vel) only gives an 85% cure rate for G3 and only if Ribavirin is added

 

Harvoni vs Sofosbuvir + Daclatasvir Hep C Genotype 1

Sof + Dac

This graph shows that 12 weeks of Sofosbuvir + Daclatasvir gives a cure rate of better than 97% for Genotype 1. Better than Maviret, Epclusa and Harvoni

 

Sofosbuvir + Daclatasvir for Hep C Genotype 2 (Co-infection)

Genotype 2

This graph shows that for people with genotype 2 a 12 week treatment of Sofosbuvir + Daclatasvir gives a 100% cure rate

 

Sofosbuvir + Daclatasvir Hep C Genotype 3: with and without cirrhosis

Genotype 3

This Graph shows that for people without cirrhosis and who have not failed a previous treatment Sof + Dac gives a 95% cure rate equal to, or better than, Epclusa or Mavyret

 

Sofosbuvir + Daclatasvir for Hep C Genotype 1.

Mavyret

This graph shows that Sofosbuvir + Daclatasvir gives 100% cure rate for G1b and a 97% cure rate for G1a. Both results are better than Harvoni, Maviret and Epclusa

 

Sofosbuvir + Daclatasvir vs Epclusa  for Hep C genotype 2 and genotype 3.

This graph shows that Sofosbuvir + Daclatasvir is equal to or better than Epclusa except where the patient has a high level of Fibrosis or Cirrhosis

 

 

Hep C treatment

This graph shows people who have not failed a previous treatment and do not have cirrhosis have a 97% cure rate from Sofosbuvir + Daclatasvir

 

 

Drugs Used For Hep C Treatment, Hep C Treatment Drugs, Hep C Treatment Drugs Cost, Hepatitis C Treatment Antiviral Drugs, Hepatitis C Treatment Drug Cost

Greg Jefferys

Greg Jefferys

2 Comments

Leave a Comment